CS logo
small CS logo
University of Nigeria Teaching Hospital

Enugu, Nigeria
Medical school in Nigeria
8F26+HQ2, 402109, Enugu

About University of Nigeria Teaching Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at University of Nigeria Teaching Hospital


During the past decade, University of Nigeria Teaching Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "University of Nigeria Teaching Hospital" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Chiba University, Japan" with 1 trials as a collaborator, "HOSEI University, Japan" with 1 trials as a collaborator, "Instituto Mexicano de Seguro Social, Mexico" with 1 trials as a collaborator and "Instituto de Biomedicina de Valencia, Spain" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

Clinical Trials Conditions at University of Nigeria Teaching Hospital


According to Clinical.Site data, the most researched conditions in "University of Nigeria Teaching Hospital" are "Gastric Cancer" (1 trials), "Intestinal Metaplasia" (1 trials), "Leg Ulcers" (1 trials), "Non-Atrophic Gastritis" (1 trials) and "Rheumatic Heart Disease" (1 trials). Many other conditions were trialed in "University of Nigeria Teaching Hospital" in a lesser frequency.

Clinical Trials Intervention Types at University of Nigeria Teaching Hospital


Most popular intervention types in "University of Nigeria Teaching Hospital" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (1 trials), "Rivaroxaban (20 mg)" (1 trials), "Vitamin K antagonists (VKA)" (1 trials) and "Voxelotor Oral Tablet" (1 trials). Other intervention names were less common.

Clinical Trials Genders at University of Nigeria Teaching Hospital


The vast majority of trials in "University of Nigeria Teaching Hospital" are 3 trials for "All" genders.

Clinical Trials Status at University of Nigeria Teaching Hospital


Currently, there are NaN active trials in "University of Nigeria Teaching Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Nigeria Teaching Hospital, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Nigeria Teaching Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".